Constitutional Court orders Nueva EPS to provide Burosumab to 10-year-old patient
Published · Updated
What happened
The Constitutional Court ordered Nueva EPS to immediately deliver Burosumab and guarantee follow-up exams and comprehensive treatment for a 10-year-old boy after finding unlawful administrative barriers in his care pathway.
Why it matters
The ruling increases legal scrutiny of how EPS entities handle access to high-cost treatments and creates a concrete compliance test for Nueva EPS in the next few days. It also provides a fresh case that patients, judges, and regulators can cite when disputing delays or denials in specialized care.
On October 1, Colombia's Constitutional Court ruled for a 10-year-old boy and ordered Nueva EPS to immediately provide Burosumab, along with follow-up testing and comprehensive treatment. The court found that the insurer had imposed unlawful administrative barriers to access. The ruling adds a new judicial signal on EPS conduct at a time when the government is under pressure to stabilize access, case resolution, and confidence in the health system.
Watch for
Nueva EPS confirmation by 2026-10-05 that Burosumab was dispensed and the treatment route was activated for the patient Constitutional Court publication of the full ruling text or compliance order in the next 72 hours Superintendencia Nacional de Salud statement or inspection action on Nueva EPS compliance with the court order by 2026-10-05 Ministry of Health acknowledgement in the next 72 hours on whether the case will inform EPS oversight or access-enforcement measures
Sources
Researched and written by AI from the sources listed, under published rules. How V³ Aware is made